Clinical Trial Update: Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial update examining immunological mechanisms of Oralair in patients with seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Oralair (grass pollen sublingual immunotherapy tablet)

Snippet

Sponsor: Bayside Health | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED